Cargando…

The pivotal role of mammalian target of rapamycin inhibition in the treatment of patients with neuroendocrine tumors

Significant advances have been made toward understanding the biology of neuroendocrine tumors (NET) in terms of defining prognosis and improving clinical management; however, many unmet needs remain. The treatment landscape for NET has evolved, with the approval of the targeted agents everolimus and...

Descripción completa

Detalles Bibliográficos
Autores principales: Phan, Alexandria T., Dave, Bhuvanesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5083749/
https://www.ncbi.nlm.nih.gov/pubmed/27539383
http://dx.doi.org/10.1002/cam4.742